Trial intelligence / Profile preview

Esketamine vs dexmedetomidine for perioperative anxiety in laparoscopic gynecologic surgery

ChiCTR2300075834Phase 4Recruiting

Sponsor
General Hospital of the Northern Theater Command
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in gynaecological conditions (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: SAS and SDS scores. Started Sep 2023; status: recruiting.

02

Drugs

esketamine
03

Conditions

gynaecological conditions

Beyond the preview

Go deeper on ChiCTR2300075834.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300075834.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call